CA939265A - Injectable compositions for alleviating the pain incurred from administrations of injections - Google Patents

Injectable compositions for alleviating the pain incurred from administrations of injections

Info

Publication number
CA939265A
CA939265A CA035,016A CA35016A CA939265A CA 939265 A CA939265 A CA 939265A CA 35016 A CA35016 A CA 35016A CA 939265 A CA939265 A CA 939265A
Authority
CA
Canada
Prior art keywords
administrations
alleviating
injections
injectable compositions
incurred
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA035,016A
Other versions
CA35016S (en
Inventor
Yoshitaka Ikezuki
Masayoshi Aruga
Yoshihisa Nozaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Application granted granted Critical
Publication of CA939265A publication Critical patent/CA939265A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA035,016A 1967-11-18 1968-11-13 Injectable compositions for alleviating the pain incurred from administrations of injections Expired CA939265A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7416367 1967-11-18
JP8117567 1967-12-20

Publications (1)

Publication Number Publication Date
CA939265A true CA939265A (en) 1974-01-01

Family

ID=26415298

Family Applications (1)

Application Number Title Priority Date Filing Date
CA035,016A Expired CA939265A (en) 1967-11-18 1968-11-13 Injectable compositions for alleviating the pain incurred from administrations of injections

Country Status (5)

Country Link
CA (1) CA939265A (en)
DE (1) DE1808948A1 (en)
ES (1) ES360364A1 (en)
FR (1) FR8217M (en)
GB (1) GB1253830A (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3984403A (en) * 1972-06-30 1976-10-05 Takeda Chemical Industries, Ltd. Arginine and lysine salts of acid cephalosporins
SE458505B (en) * 1979-07-10 1989-04-10 Lepetit Spa APPLICATION OF RIFAMYCIN SV AND SALTS THEREOF PREPARING A PREPARATION FOR TREATMENT OF REUMATOID ARTHRITIS AND CERTAIN SALTS AND THEIR PREPARATION
IT1127322B (en) * 1979-12-28 1986-05-21 Italfarmaco Spa PHARMACEUTICAL COMPOSITIONS WITH EXHALATION OF THE THERAPEUTIC ACTIVITY OF CORTISONICS
US4605557A (en) * 1982-09-07 1986-08-12 Tetra Consultants, Inc. Method of producing allergenic extracts
US4600582A (en) * 1982-09-07 1986-07-15 Tetra Consultants, Inc. Therapeutic treatment
GB2199243A (en) * 1986-09-17 1988-07-06 Natural Vitality Ltd Pharmaceutical compositions comprising ornithine and arginine
SE468881B (en) * 1991-01-09 1993-04-05 Kabi Pharmacia Ab APPLICATION OF CERTAIN PHARMACEUTICALS FOR THE PREPARATION OF MEDICINAL PRODUCTS FOR TREATMENT OF ENDOTOXIN-INDEXED EFFECTS AND THE PREPARATION OF ENDOTOXINES FROM MISCELLANEOUS SOLUTIONS
JP4671092B2 (en) * 2003-11-20 2011-04-13 森重 文江 Virus infection prevention and countermeasures
EP2033689A1 (en) * 2007-08-22 2009-03-11 Italfarmacia S.r.l. Injectable dermatological composition for treatment of the wrinkles

Also Published As

Publication number Publication date
DE1808948A1 (en) 1969-07-10
ES360364A1 (en) 1970-10-16
GB1253830A (en) 1971-11-17
FR8217M (en) 1970-09-21

Similar Documents

Publication Publication Date Title
CA939265A (en) Injectable compositions for alleviating the pain incurred from administrations of injections
CA940450A (en) Injectable therapeutic compositions
CA920366A (en) Fuel compositions
CA764861A (en) Bituminous compositions
AU428104B2 (en) Stabilised compositions of unsaturated polyesters
CA728620A (en) Pharmaceutical compositions for the suppression of appetite
CA725098A (en) Vapor phase corrosion inhibiting composition
CA772595A (en) Stabilized dental compositions
AU3675968A (en) Stabilised compositions of unsaturated polyesters
AU406670B2 (en) Fuel compositions
CA762485A (en) Acaricidal compositions
CA729108A (en) Stabilized hydrocarbon compositions
AU406112B1 (en) Curing compositions for polyesters
CA763471A (en) Ferroelectric ceramic compositions
AU424505B2 (en) Stabilised co-enzyme test compositions
AU432857B2 (en) Bituminous compositions
CA763326A (en) Bituminous compositions
CA678084A (en) Polyamidoether-titanium ester compositions
CA688061A (en) Fuel compositions
AU409105B2 (en) Stabilised chlorofluoroalkane-polyol compositions
AU2153867A (en) Fuel compositions
CA729107A (en) Fuel compositions
CA736420A (en) Fuel compositions
CA745162A (en) Ester compositions
CA768639A (en) Ester composition